MarketAxess Reports First Quarter 2015 Record Revenues of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MarketAxess Reports First Quarter 2015 Record Revenues of $76.8 Million, Record Pre-Tax Income of $38.5 Million and Record Diluted EPS of $0.65

First Quarter Financial Highlights *

  • Record revenues of $76.8 million, up 21.1%
  • Record pre-tax income of $38.5 million, up 39.0%
  • Record diluted EPS of $0.65, up from $0.46
  • Record total trading volume of $243.7 billion, up 30.0%

* All comparisons versus first quarter 2014.

NEW YORK, April 22, 2015 (GLOBE NEWSWIRE) -- MarketAxess Holdings Inc. (Nasdaq: MKTX ), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the global fixed-income markets, today announced results for the quarter ended March 31, 2015.

"We are happy with the strong start to 2015 with record revenues, pre-tax income and EPS, driven by year-over-year volume and market share growth across all of our key products," said Richard M. McVey, Chairman and CEO of MarketAxess. "Our investment in Open Trading is delivering greater value to our clients through expanded liquidity sources and lower transaction costs. We also saw continued momentum in our European business, as enhancements to our trading system and the launch of unique data tools helped drive significant trading volume gains."

First Quarter Results

Total revenues for the first quarter of 2015 increased 21.1% to a record $76.8 million, compared to $63.4 million for the first quarter of 2014. Pre-tax income was a record $38.5 million, compared to $27.7 million for the first quarter of 2014, an increase of 39.0%. Pre-tax margin was 50.2%, compared to 43.7% for the first quarter of 2014. Net income totaled $24.6 million, or $0.65 per share on a diluted basis, compared to $17.5 million, or $0.46 per share, for the first quarter of 2014.

Commission revenue for the first quarter of 2015 increased 28.9% to a record $67.0 million, compared to $52.0 million for the first quarter of 2014. Variable transaction fees increased 43.3% to $51.3 million on total trading volume of $243.7 billion for the first quarter of 2015, compared to variable transaction fees of $35.8 million on total trading volume of $187.4 billion for the first quarter of 2014. U.S. high-grade trading volume as a percentage of FINRA's high-grade TRACE trading volume increased to an estimated 15.6% on an adjusted basis, compared to an estimated 13.4% for the first quarter of 2014. See Non-GAAP Financial Measures and Other Items below for further information on FINRA TRACE volume and U.S. high-grade market share.

All other revenue, which consists of information and post-trade services, technology products and services, investment income and other revenue, decreased to $9.8 million for the first quarter of 2015, compared to $11.4 million for the first quarter of 2014. Lower technology-related professional consulting services fees and the unfavorable impact of the strengthening U.S. dollar accounted for the decline in all other revenue.

Total expenses for the first quarter of 2015 increased 7.2% to $38.3 million, compared to $35.7 million for the first quarter of 2014. The increase in total expenses was principally due to higher employee compensation and benefits costs of $2.6 million.

The effective tax rate for the first quarter of 2015 was 36.1%, compared to 36.9% for the first quarter of 2014.

Dividend

The Company's board of directors declared a quarterly cash dividend of $0.20 per share of common stock outstanding, to be paid on May 21, 2015 to stockholders of record as of the close of business on May 7, 2015.

Share Repurchase Program

A total of 117,400 shares were repurchased in the first quarter of 2015 at a cost of $8.9 million under the Company's $100.0 million share repurchase program. As of March 31, 2015, approximately $53.1 million was available for future repurchases under the program.

Balance Sheet Data

As of March 31, 2015, total assets were $378.7 million and included $223.2 million in cash, cash equivalents and securities available-for-sale. Total stockholders' equity as of March 31, 2015 was $344.7 million.

Non-GAAP Financial Measures and Other Items

To supplement the Company's unaudited financial statements presented in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP measures of financial performance, including earnings before interest, taxes, depreciation and amortization ("EBITDA"). The Company believes that these non-GAAP financial measures, when taken into consideration with the corresponding GAAP financial measures, are important in understanding the Company's operating results. See the attached schedule for a reconciliation of GAAP net income to EBITDA.

For purposes of calculating U.S. high-grade estimated market share, FINRA TRACE volumes have been adjusted to eliminate the increased reporting of affiliate back-to-back trade to FINRA beginning in April 2014 and the inclusion of 144A securities beginning in July 2014. Based on information provided by FINRA, the Company believes that adjusted FINRA TRACE volumes provide a more accurate comparison to prior period reporting. The Company has provided a reconciliation of U.S. high-grade TRACE volumes to the adjusted U.S. high-grade TRACE volumes on the "Investor Relations-Volume" section of its website.

Webcast and Conference Call Information

Richard M. McVey, chairman and chief executive officer, and Antonio L. DeLise, chief financial officer, will host a conference call to discuss the Company's financial results and outlook on Wednesday, April 22, 2015, at 10:00 a.m. Eastern time. To access the conference call, please dial 855-425-4206 (U.S.) or 484-756-4249 (international). The Company will also host a live audio Webcast of the conference call on the Investor Relations section of the Company's website at http://investor.marketaxess.com . A replay of the call will be made available by dialing 855-859-2056 (U.S.) or 404-537-3406 (international) for one week after the announcement. The Webcast will also be archived on http://investor.marketaxess.com for 90 days following the announcement.

About MarketAxess

MarketAxess operates a leading electronic trading platform that enables fixed-income market participants to efficiently trade corporate bonds and other types of fixed-income instruments using MarketAxess' patented trading technology. Over 1,000 institutional investor and broker-dealer firms are active users of the MarketAxess trading platform, accessing global liquidity in U.S. high-grade corporate bonds, emerging markets and high-yield bonds, European bonds, U.S. agency bonds, credit default swaps and other fixed-income securities. MarketAxess SEF Corporation has received temporary registration from the U.S. Commodity Futures Trading Commission to operate a swap execution facility. MarketAxess also offers a number of trading-related products and services, including: market data to assist clients with trading decisions; connectivity solutions that facilitate straight-through processing; technology services to optimize trading environments; and execution services for exchange-traded fund managers and other clients. Through its Trax® division, MarketAxess also offers a range of pre- and post-trade services, including trade matching, regulatory transaction reporting and market and reference data, across a range of fixed-income products. Trax is the trading name of Xtrakter Ltd., a MarketAxess group company.

MarketAxess maintains its headquarters in New York and has offices in London, Boston, Chicago, Los Angeles, Salt Lake City, São Paulo and Singapore. For more information, please visit www.marketaxess.com .

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including statements about the outlook and prospects for Company and industry growth, as well as statements about the Company's future financial and operating performance. These and other statements that relate to future results and events are based on MarketAxess' current expectations. The Company's actual results in future periods may differ materially from those currently expected or desired because of a number of risks and uncertainties, including: the volatility of financial services markets generally; the level of trading volume transacted on the MarketAxess platform; the absolute level and direction of interest rates and the corresponding volatility in the corporate fixed-income market; the level and intensity of competition in the fixed-income electronic trading industry and the pricing pressures that may result; the variability of our growth rate; the rapidly evolving nature of the electronic financial services industry; our ability to introduce new fee plans and our clients' response; our exposure to risks resulting from non-performance by counterparties to transactions executed between our clients in which we act as an intermediary in matched principal trades; our dependence on our broker-dealer clients; the loss of any of our significant institutional investor clients; our ability to develop new products and offerings and the market's acceptance of those products; the effect of rapid market or technological changes on us and the users of our technology; our ability to successfully maintain the integrity of our trading platform and our response to system failures, capacity constraints and business interruptions; our vulnerability to cyber security risks; our ability to protect our intellectual property rights or technology and defend against intellectual property infringement or other claims; our ability to enter into strategic alliances and to acquire other businesses and successfully integrate them with our business; our ability to comply with new laws, rules and regulations both domestically and internationally; our ability to maintain effective compliance and risk management methods; the strain of growth initiatives on management and other resources; our future capital needs and our ability to obtain capital when needed; limitations on our operating flexibility contained in our credit agreement; and other factors. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. More information about these and other factors affecting MarketAxess' business and prospects is contained in MarketAxess' periodic filings with the Securities and Exchange Commission and can be accessed at www.marketaxess.com .

MarketAxess Holdings Inc.
Consolidated Statements of Operations
 
  Three Months Ended March 31,
  2015 2014
  (In thousands, except per share data)
  (unaudited)
Revenues    
Commissions  $ 67,018  $ 51,989
Information and post-trade services  7,679  8,079
Technology products and services  1,420  2,036
Investment income  183  146
Other  471  1,148
Total revenues  76,771  63,398
     
Expenses    
Employee compensation and benefits  21,174  18,609
Depreciation and amortization  4,612  4,121
Technology and communications  4,338  4,492
Professional and consulting fees  3,282  3,972
Occupancy  992  1,089
Marketing and advertising  1,192  1,209
General and administrative  2,679  2,198
Total expenses  38,269  35,690
     
Income before taxes  38,502  27,708
Provision for income taxes  13,909  10,233
Net income  $ 24,593  $ 17,475
Per Share Data:    
Net income per common share    
Basic  $ 0.67  $ 0.47
Diluted  $ 0.65  $ 0.46
     
Cash dividends declared per common share  $ 0.20  $ 0.16
     
Weighted-average common shares:    
Basic  36,706  37,121
Diluted  37,626  38,096
 
MarketAxess Holdings Inc.
Consolidated Condensed Balance Sheet Data
 
  As of
  March 31, 2015 December 31, 2014
     
  (In thousands)
  (unaudited)
Assets    
Cash and cash equivalents  $ 161,048  $ 168,924
Securities available-for-sale  62,195  64,863
Accounts receivable, net  46,062  33,836
All other assets  109,389  112,261
Total assets  $ 378,694  $ 379,884
     
Liabilities and Stockholders' Equity    
Total liabilities  34,024  45,676
Total stockholders' equity  344,670  334,208
Total liabilities and stockholders' equity  $ 378,694  $ 379,884
 
MarketAxess Holdings Inc.
Reconciliation of Non-GAAP Financial Measures
Earnings Before Interest, Taxes, Depreciation and Amortization
 
  Three Months Ended
  March 31,
  2015 2014
  (In thousands)
  (unaudited)
Net income  $ 24,593  $ 17,475
Add back:    
Interest expense  --   -- 
Provision for income taxes  13,909  10,233
Depreciation and amortization  4,612  4,121
     
Earnings before interest, taxes, depreciation and amortization  $ 43,114  $ 31,829
 
MarketAxess Holdings Inc.
Volume Statistics
 
  Three Months Ended March 31,
  2015 2014
     
   Total Trading Volume 
  (In millions)
  (unaudited)
U.S. high grade - fixed-rate  $ 137,987  $ 113,128
U.S. high grade - floating-rate  7,395  6,036
Total U.S. high-grade  145,382  119,164
Other credit  81,619  50,050
Liquid products  16,675  18,203
Total  $ 243,676  $ 187,417
     
   Average Daily Volume 
  (In millions)
  (unaudited)
U.S. high-grade  $ 2,383  $ 1,954
Other credit  1,327  816
Liquid products  273  298
Total  $ 3,983  $ 3,068
     
Number of U.S. Trading Days 1  61  61
Number of U.K. Trading Days 2  63  63
     
   Average Variable Transaction Fee Per Million 
  (unaudited)
U.S. high grade - fixed-rate  $ 192  $ 173
U.S. high grade - floating-rate  46  60
Total U.S. high-grade  185  167
Other credit  291  301
Liquid products  42  45
Total  211  191
 
1 The number of U.S. trading days is based on the SIFMA holiday recommendation calendar.
2 The number of U.K. trading days is based on the U.K. Bank holiday schedule.
 
*Consistent with FINRA TRACE reporting standards, both sides of trades are included in the Company's reported volumes when the Company executes trades on a riskless principal basis between two counterparties.

Media and Investor Relations Contacts: Tony DeLise MarketAxess Holdings Inc. +1-212-813-6017 Florencia Panizza MarketAxess Holdings Inc. +1-212-813-6029 William McBride Bryant Park Financial Communications +1-917-239-6726

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading